Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Closes 155 Points Higher; Realty & Telecom Stocks Outperform
Mon, 7 Jan Closing

Indian share markets ended the day on a positive note, though off their high points. At the closing bell, BSE Sensex ended up by 155 points, while, NSE Nifty ended up by 49 points.

Barring metal stocks, capital goods stocks and healthcare stocks, all sectoral indices ended in green with realty stocks and telecom stocks witnessing maximum buying interest.

Globally, Asian stock markets finished broadly higher today with shares in Japan leading the region. The Nikkei 225 is up 2.4% while Hong Kong's Hang Seng is up 0.8% and China's Shanghai Composite is up 0.7%. European markets are lower today with shares in France off the most. The CAC 40 is down 0.2% while London's FTSE 100 is off 0.2% and Germany's DAX is lower by 0.1%.

Pharma stocks ended the day on a mixed note with Ajanta Pharma & Aarti Drugs leading the pack of gainers. As per an article in a leading financial daily, Lupin has received approval from the United States Food and Drug Administration (USFDA) for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg.

It has received approval to market a generic version of Sunovion Pharmaceuticals, Inc's Latuda Tablets.

Lupin's Lurasidone Hydrochloride Tablets is indicated for the treatment of adult patients with schizophrenia, monotherapy treatment of adult patients with major depressive episode associated with bipolar I disorder.

Reportedly, Latuda tablets had annual sales of approximately US$3217.3 million in the US (IQVIA MAT September 2018).

To know more about the company, you can access to Lupin's Q2FY19 result analysis and Lupin's 2017-18 Annual Report Analysis on our website.

Lupin share price ended the day down by 1.1%.

--- Advertisement ---
The 'Infinite Return' Stock to Buy Now

Sarvajeet, co-editor of Smart Money Secrets, calls this an 'Infinite Return Business'…

It has a grand total of ONE company as competition – and tough industry regulations make it near impossible for a new player to get in.

And even within this duopoly, this company is steadily gaining market share by targeting a segment the other company is staying away from…

The best part?

This company has ZERO debt and a huge amount of cash on its balance sheet.

Sarvajeet has sent his subscribers a recommendation report with full details on this exciting find.

Here's how you can get access…
------------------------------

Moving on to the news from finance sector. As per an article in a leading financial daily, IL&FS Transportation Networks, a group company of the troubled IL&FS group, defaulted on dividend payment of Rs 71.2 million due on redemption of cumulative non-convertible redeemable preference shares.

Reportedly, the dividend of Rs 71.2 million was due for the period between 1 April 2017 to 23 December 2018 and was not paid due to insufficient funds.

Note that, IL&FS and its subsidiaries have defaulted on many debt instruments in the past few months due to insufficient funds.

The group's total debt stood at over Rs 940 billion as of October 2018.

Speaking of the IL&FS crisis, Tanushree Banerjee, co-head of Research at Equitymaster, rightly pointed out in The 5 Minute WrapUp, that rating agencies were late to ring the alarm bells this time as well.

Here's what Tanushree wrote:

Rising NPAs and Debt - Early Indicators of IL&FS' Liquidity Crisis

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex Closes 155 Points Higher; Realty & Telecom Stocks Outperform". Click here!